PMID- 26732303 OWN - NLM STAT- MEDLINE DCOM- 20160712 LR - 20201209 IS - 1879-0038 (Electronic) IS - 0378-1119 (Linking) VI - 581 IP - 1 DP - 2016 Apr 25 TI - Mg(++) requirement for MtHK binding, and Mg(++) stabilization of mitochondrial membranes via activation of MtHK & MtCK and promotion of mitochondrial permeability transition pore closure: A hypothesis on mechanisms underlying Mg(++)'s antioxidant and cytoprotective effects. PG - 1-13 LID - S0378-1119(15)01544-9 [pii] LID - 10.1016/j.gene.2015.12.046 [doi] AB - Evidence points to magnesium's antioxidant, anti-necrotic, and anti-apoptotic effects in cardio- and neuroprotection. With magnesium being involved in over 300 biochemical reactions, the mechanisms underlying its cytoprotective and antioxidant effects have remained elusive. The profound anti-apoptotic, anabolic, and antioxidant effects of mitochondrion bound hexokinase (MtHk), and the anti-apoptotic, anti-necrotic, and antioxidant functions of mitochondrial creatine kinase (MtCK) have been established over the past few decades. As powerful regulators of the mitochondrial permeability transition pore (PTP), MtHK and MtCK promote anti-apoptosis and anti-necrosis by stabilizing mitochondrial outer and inner membranes. In this article, it is proposed that magnesium is essentially and directly involved in mitochondrial membrane stabilization via (i) Mg(++) ion requirement for the binding of mitochondrial hexokinase (ii) Mg(++)'s allosteric activation of mitochondrial bound hexokinase, and stimulation of mitochondrial bound creatine kinase activities, and (iii) Mg(++) inhibition of PTP opening by Ca(++) ions. These effects of Mg(++) ions are indirectly supplanted by the stimulatory effect of magnesium on the Akt kinase survival pathway. The "Magnesium/Calcium Yin Yang Hypothesis" proposes here that because of the antagonistic effects of Ca(++) and Mg(++) ions in the presence of high Ca(++) ion concentration at MtHK, MtCK, and PTP, magnesium supplementation may provide cytoprotective effects in the treatment of some degenerative diseases and cytopathies with high intracellular [Ca(++)]/ [Mg(++)] ratio at these sites, whether of genetic, developmental, drug induced, ischemic, immune based, toxic, or infectious etiology. CI - Copyright (c) 2015 Elsevier B.V. All rights reserved. FAU - Golshani-Hebroni, Shiva AU - Golshani-Hebroni S LA - eng PT - Journal Article PT - Review DEP - 20151228 PL - Netherlands TA - Gene JT - Gene JID - 7706761 RN - 0 (Antioxidants) RN - 0 (Mitochondrial Membrane Transport Proteins) RN - 0 (Mitochondrial Permeability Transition Pore) RN - EC 2.7.1.1 (Hexokinase) RN - EC 2.7.3.2 (Creatine Kinase) RN - I38ZP9992A (Magnesium) RN - SY7Q814VUP (Calcium) SB - IM MH - Animals MH - Antioxidants/*metabolism MH - Calcium/metabolism MH - *Cold Temperature MH - Creatine Kinase/metabolism MH - Enzyme Activation MH - Hexokinase/*metabolism MH - Magnesium/*metabolism MH - Mitochondrial Membrane Transport Proteins/*metabolism MH - Mitochondrial Membranes/*enzymology MH - Mitochondrial Permeability Transition Pore MH - Protein Binding OTO - NOTNLM OT - ATP synthase OT - Magnesium OT - anti-apoptosis OT - anti-necrosis OT - antioxidant OT - apoptosis OT - calcium OT - cardioprotection OT - cytoprotection OT - degenerative disease OT - hexokinase OT - mitochondrial bound hexokinase OT - mitochondrial creatine kinase OT - mitochondrial permeability transition pore OT - necrosis OT - neuroprotection EDAT- 2016/01/07 06:00 MHDA- 2016/07/13 06:00 CRDT- 2016/01/07 06:00 PHST- 2015/05/09 00:00 [received] PHST- 2015/12/15 00:00 [revised] PHST- 2015/12/16 00:00 [accepted] PHST- 2016/01/07 06:00 [entrez] PHST- 2016/01/07 06:00 [pubmed] PHST- 2016/07/13 06:00 [medline] AID - S0378-1119(15)01544-9 [pii] AID - 10.1016/j.gene.2015.12.046 [doi] PST - ppublish SO - Gene. 2016 Apr 25;581(1):1-13. doi: 10.1016/j.gene.2015.12.046. Epub 2015 Dec 28.